UBS Group’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.26M | Sell |
880,873
-245,931
| -22% | -$2.31M | ﹤0.01% | 2590 |
|
|
2025
Q1 | $8.01M | Sell |
1,126,804
-614,964
| -35% | -$4.37M | ﹤0.01% | 2570 |
|
|
2024
Q4 | $20.3M | Buy |
1,741,768
+1,463,336
| +526% | +$17.1M | ﹤0.01% | 1745 |
|
|
2024
Q3 | $5.72M | Buy |
278,432
+22,881
| +9% | +$470K | ﹤0.01% | 2160 |
|
|
2024
Q2 | $5.72M | Sell |
255,551
-76,035
| -23% | -$1.7M | ﹤0.01% | 2022 |
|
|
2024
Q1 | $9.12M | Buy |
331,586
+57,062
| +21% | +$1.57M | ﹤0.01% | 1671 |
|
|
2023
Q4 | $8.37M | Buy |
274,524
+150,517
| +121% | +$4.59M | ﹤0.01% | 1581 |
|
|
2023
Q3 | $3.92M | Sell |
124,007
-10,862
| -8% | -$343K | ﹤0.01% | 2037 |
|
|
2023
Q2 | $5.5M | Buy |
134,869
+45,495
| +51% | +$1.86M | ﹤0.01% | 1819 |
|
|
2023
Q1 | $3.33M | Sell |
89,374
-92,237
| -51% | -$3.44M | ﹤0.01% | 2162 |
|
|
2022
Q4 | $6.34M | Buy |
181,611
+132,643
| +271% | +$4.63M | ﹤0.01% | 1649 |
|
|
2022
Q3 | $2.74M | Buy |
48,968
+2,054
| +4% | +$115K | ﹤0.01% | 2126 |
|
|
2022
Q2 | $2.43M | Sell |
46,914
-52,265
| -53% | -$2.71M | ﹤0.01% | 2257 |
|
|
2022
Q1 | $7.21M | Sell |
99,179
-15,969
| -14% | -$1.16M | ﹤0.01% | 1666 |
|
|
2021
Q4 | $13.6M | Buy |
115,148
+50,694
| +79% | +$5.99M | ﹤0.01% | 1337 |
|
|
2021
Q3 | $8.65M | Buy |
64,454
+15,039
| +30% | +$2.02M | ﹤0.01% | 1601 |
|
|
2021
Q2 | $8M | Sell |
49,415
-2,696
| -5% | -$437K | ﹤0.01% | 1661 |
|
|
2021
Q1 | $4.18M | Sell |
52,111
-73,838
| -59% | -$5.93M | ﹤0.01% | 2123 |
|
|
2020
Q4 | $6.85M | Buy |
125,949
+50,413
| +67% | +$2.74M | ﹤0.01% | 1613 |
|
|
2020
Q3 | $1.5M | Sell |
75,536
-10,204
| -12% | -$203K | ﹤0.01% | 2643 |
|
|
2020
Q2 | $1.8M | Buy |
85,740
+4,071
| +5% | +$85.6K | ﹤0.01% | 2363 |
|
|
2020
Q1 | $999K | Sell |
81,669
-33,065
| -29% | -$404K | ﹤0.01% | 2662 |
|
|
2019
Q4 | $1.68M | Sell |
114,734
-110,980
| -49% | -$1.63M | ﹤0.01% | 2912 |
|
|
2019
Q3 | $3.01M | Buy |
225,714
+71,391
| +46% | +$953K | ﹤0.01% | 2275 |
|
|
2019
Q2 | $2.53M | Buy |
154,323
+13,187
| +9% | +$216K | ﹤0.01% | 2335 |
|
|
2019
Q1 | $2.41M | Sell |
141,136
-63,465
| -31% | -$1.08M | ﹤0.01% | 2298 |
|
|
2018
Q4 | $2.79M | Buy |
204,601
+66,702
| +48% | +$911K | ﹤0.01% | 2150 |
|
|
2018
Q3 | $3.95M | Buy |
137,899
+16,994
| +14% | +$486K | ﹤0.01% | 2073 |
|
|
2018
Q2 | $3.31M | Sell |
120,905
-70,711
| -37% | -$1.93M | ﹤0.01% | 2169 |
|
|
2018
Q1 | $4.04M | Buy |
191,616
+108,878
| +132% | +$2.3M | ﹤0.01% | 2019 |
|
|
2017
Q4 | $1.59M | Buy |
82,738
+13,114
| +19% | +$252K | ﹤0.01% | 2689 |
|
|
2017
Q3 | $1.73M | Buy |
69,624
+7,320
| +12% | +$182K | ﹤0.01% | 2596 |
|
|
2017
Q2 | $997K | Buy |
62,304
+1,369
| +2% | +$21.9K | ﹤0.01% | 2914 |
|
|
2017
Q1 | $859K | Buy |
60,935
+49,480
| +432% | +$698K | ﹤0.01% | 2951 |
|
|
2016
Q4 | $150K | Buy |
11,455
+10,038
| +708% | +$131K | ﹤0.01% | 4120 |
|
|
2016
Q3 | $24K | Buy |
1,417
+417
| +42% | +$7.06K | ﹤0.01% | 5262 |
|
|
2016
Q2 | $21K | Buy |
+1,000
| New | +$21K | ﹤0.01% | 5385 |
|